A retrospective comparison of active surveillance to stereotactic radiosurgery for the management of elderly patients with an incidental meningioma
Jazyk angličtina Země Rakousko Médium electronic
Typ dokumentu časopisecké články, srovnávací studie, multicentrická studie
PubMed
39912992
PubMed Central
PMC11802698
DOI
10.1007/s00701-025-06452-4
PII: 10.1007/s00701-025-06452-4
Knihovny.cz E-zdroje
- Klíčová slova
- Elderly, Meningioma, Stereotactic radiosurgery, Surveillance,
- MeSH
- lidé MeSH
- meningeální nádory * chirurgie radioterapie mortalita MeSH
- meningeom * chirurgie radioterapie mortalita MeSH
- náhodný nález MeSH
- pozorné vyčkávání * MeSH
- radiochirurgie * metody MeSH
- retrospektivní studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- tendenční skóre MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- srovnávací studie MeSH
INTRODUCTION: Management for elderly patients (> 65yo) with incidental meningiomas remains unclear. This study aims to characterize the functional and tumor outcomes of expectant and stereotactic radiosurgery (SRS) management of asymptomatic meningioma elderly patients. METHODS: Using retrospectively collected data from 14 centers, SRS outcomes were compared to radiographic and clinical observation of asymptomatic meningiomas in elderly patients following propensity score matching. RESULTS: Following propensity score matching, 114 patients were in each cohort. Tumor control was achieved at 97.37% in the SRS cohort, and no meningioma growth was seen 71.93% of the observation cohorts (p < 0.01; OR 14.44 [95% CI 4.27-48.78]). New neurological deficits developed in 1.39% of the SRS cohort but in none of the patients managed conservatively. 3.5% of patients underwent resection in the active surveillance matched cohort compared to 0.9% of patients in the SRS cohort (p = 0.063; OR 0.135 [95% CI 0.163-1.117]). The all-cause mortality rate was almost half in the SRS group (9.65%) compared to the observation group (18.42%) (p = 0.06; OR 0.47 [95% CI .22-1.03]). CONCLUSION: SRS achieves superior radiological tumor control compared to surveillance but with a slightly increased the risk of new SRS-related neurological deficits in elderly patients with asymptomatic meningiomas. Although SRS reduces meningioma progression, the need for of an open neurosurgical procedure and mortality were not significantly reduced. Furthermore, mortality in the observation group was not directly related to the meningioma in any of the patients.
Department of Neurological Surgery Mayo Clinic Rochester MN USA
Department of Neurological Surgery University of Virginia P O Box 800212 Charlottesville VA USA
Department of Neurosurgery Koc University School of Medicine Istanbul Turkey
Department of Neurosurgery New York University New York NY USA
Department of Neurosurgery University of Alberta Edmonton AB Canada
Department of Neurosurgery University of Miami Miller School of Medicine Miami FL USA
Department of Neurosurgery University of Pittsburgh Pittsburgh PA USA
Department of Radiation and Stereotactic Neurosurgery Na Homolce Hospital Prague Czech Republic
Department of Radiation Oncology New York University New York NY USA
Department of Radiosurgery Rúber International Hospital Madrid Spain
Division of Neurosurgery Université de Sherbrooke Centre de Recherche du CHUS Sherbrooke QC Canada
Gamma Knife Center Cairo Nasser Institute Benha University Benha Egypt
Zobrazit více v PubMed
Achey RL, Gittleman H, Schroer J et al (2019) Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the central brain tumor registry of the United States. Neuro Oncol 21:380. 10.1093/NEUONC/NOY162 PubMed PMC
Agarwal V, McCutcheon BA, Hughes JD et al (2017) Trends in management of intracranial meningiomas: analysis of 49,921 cases from modern cohort. World Neurosurg 106:145–151. 10.1016/J.WNEU.2017.06.127 PubMed
Cea-Soriano L, Wallander MA, Garca Rodrguez LA (2012) Epidemiology of meningioma in the United Kingdom. Neuroepidemiology 39:27–34. 10.1159/000338081 PubMed
Di Cristofori A, Zarino B, Bertani G et al (2018) Surgery in elderly patients with intracranial meningioma: neuropsychological functioning during a long term follow-up. J Neurooncol 137:611–619. 10.1007/S11060-018-2754-3 PubMed
Dolecek TA, Dressler EVM, Thakkar JP et al (2015) Epidemiology of meningiomas post-Public Law 107–206: the benign brain tumor cancer registries amendment act. Cancer 121:2400–2410. 10.1002/CNCR.29379 PubMed PMC
Goldbrunner R, Stavrinou P, Jenkinson MD et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821–1834. 10.1093/NEUONC/NOAB150 PubMed PMC
Hasegawa H, Hanakita S, Shin M et al (2018) Single-fractionated stereotactic radiosurgery for intracranial meningioma in elderly patients: 25-year experience at a single institution. Oper Neurosurg (Hagerstown) 14:341–350. 10.1093/ONS/OPX109 PubMed
Hashiba T, Moto NH, Izumoto S et al (2009) Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas: clinical article. J Neurosurg 110:675–684. 10.3171/2008.8.JNS08481 PubMed
Huang RY, Bi WL, Weller M et al (2019) Proposed response assessment and endpoints for meningioma clinical trials: report from the response assessment in neuro-oncology working group. Neuro Oncol 21:26. 10.1093/NEUONC/NOY137 PubMed PMC
Islim AI, Mohan M, Moon RDC et al (2019) Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol 142:211–221. 10.1007/S11060-019-03104-3 PubMed PMC
Islim AI, Kolamunnage-Dona R, Mohan M et al (2020) A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas. Neuro Oncol 22:278–289. 10.1093/NEUONC/NOZ160 PubMed PMC
Islim AI, Millward CP, Piper RJ et al (2022) External validation and recalibration of an incidental meningioma prognostic model – IMPACT: protocol for an international multicentre retrospective cohort study. BMJ Open 12:e052705. 10.1136/BMJOPEN-2021-052705 PubMed PMC
Kuratsu JI, Kochi M, Ushio Y (2000) Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766–770. 10.3171/JNS.2000.92.5.0766 PubMed
Lee EJ, Kim JH, Park ES et al (2017) A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas. J Neurosurg 127:971–980. 10.3171/2016.9.JNS161669 PubMed
Meskal I, Gehring K, Rutten GJM, Sitskoorn MM (2016) Cognitive functioning in meningioma patients: a systematic review. J Neurooncol 128:195. 10.1007/S11060-016-2115-Z PubMed PMC
Näslund O, Strand PS, Solheim O et al (2023) Incidence, management, and outcome of incidental meningioma: what has happened in 10 years? J Neurooncol 165:291. 10.1007/S11060-023-04482-5 PubMed PMC
Niiro M, Yatsushiro K, Nakamura K et al (2000) Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 68:25–28. 10.1136/JNNP.68.1.25 PubMed PMC
Nowosielski M, Galldiks N, Iglseder S et al (2017) Diagnostic challenges in meningioma. Neuro Oncol 19:1588–1598. 10.1093/NEUONC/NOX101 PubMed PMC
Ostrom QT, Patil N, Cioffi G et al (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22:iv1. 10.1093/NEUONC/NOAA200 PubMed PMC
Ostrom QT, Price M, Neff C et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol 24:v1–v95. 10.1093/NEUONC/NOAC202 PubMed PMC
Rueß D, Weyer V, Tutunji J et al (2020) Stereotactic radiosurgery of benign brain tumors in elderly patients: evaluation of outcome and toxicity. Radiat Oncol 15:274. 10.1186/S13014-020-01714-0 PubMed PMC
Santacroce A, Walier M, Régis J et al (2012) Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 70:32–39. 10.1227/NEU.0B013E31822D408A PubMed
Sheehan J, Pikis S, Islim AI et al (2022) An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study. Neuro Oncol 24:116–124. 10.1093/NEUONC/NOAB132 PubMed PMC
Sughrue ME, Rutkowski MJ, Aranda D et al (2010) Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg 113:1036–1042. 10.3171/2010.3.JNS091966 PubMed
Sun C, Dou Z, Wu J et al (2020) The preferred locations of meningioma according to different biological characteristics based on voxel-wise analysis. Front Oncol 10:1412. 10.3389/FONC.2020.01412 PubMed PMC
Tucha O, Smely C, Lange KW (2001) Effects of surgery on cognitive functioning of elderly patients with intracranial meningioma. Br J Neurosurg 15:184–188. 10.1080/02688690151127608 PubMed
Whittle IR, Smith C, Navoo P, Collie D (2004) Meningiomas. The Lancet 363:1535–1543. 10.1016/S0140-6736(04)16153-9 PubMed
Withrow DR, Devesa SS, Deapen D et al (2021) Non-malignant meningioma and vestibular schwannoma incidence trends in the United States, 2004–2017. Cancer 127:3579. 10.1002/CNCR.33553 PubMed PMC
Wrensch M, Minn Y, Chew T et al (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278–299. 10.1093/NEUONC/4.4.278 PubMed PMC